eClinical Solutions LLC, a Boston, MA-based provider of digital clinical software and services, received a growth investment from GI Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to advance the future of digital trials via continued enhancements to its AI-powered data products and biometrics services.
Led by Raj Indupuri, co-founder and CEO, who will continue to lead the company along with the current management team, eClinical Solutions provides a data & analytics platform, elluminate®, and biometrics services experts, who help biopharma researchers at large, mid-size, and emerging life sciences organizations manage trial complexity. Clients get accurate data insights for better decision-making – enabling them to reduce cycle times, improve productivity, easily scale, and develop tomorrow’s breakthroughs with today’s resources.
Summit Partners, an investor in eClinical since 2020, will continue to hold a minority position in the company. eClinical’s founders will also retain a significant equity stake alongside GI Partners.
FinSMEs
12/09/2024